FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eiichi Nakayama

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Disorders

Procedures

Co-author Network

Publications

TOP 3
Shingo Eikawa; Kazuhiro Ikeuchi; Midori Isobe; Kazuhiro Kakimi; Kiyotaka Kuzushima; Immanuel Luescher; Hiroyoshi Nishikawa; Yoshihiro Ohue; Mikio Oka; Heiichiro Udono; Akiko Uenaka; Eiichi Nakayama
Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.
Hisashi Wada; Yuichiro Doki; Eiichi Nakayama
[Immune monitoring and cancer vaccine].
Junji Kawada; Hiroshi Miyata; Naoaki Mizuno; Roger Murphy; Yurika Nakamura; Yuichiro Doki; Shinichi Fujiwara; Sacha Gnjatic; Midori Isobe; Achim A Jungbluth; Hiroyoshi Nishikawa; Nami Okazaki; Lloyd J Old; Linda Pan; Erika Ritter; Gerd Ritter; Takashi Saika; Akiko Uenaka; Ralph Venhaus; Hisashi Wada; Makoto Yamasaki; Eiichi Nakayama
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eiichi Nakayama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shingo Eikawa; Kazuhiro Ikeuchi; Midori Isobe; Kazuhiro Kakimi; Kiyotaka Kuzushima; Immanuel Luescher; Hiroyoshi Nishikawa; Yoshihiro Ohue; Mikio Oka; Heiichiro Udono; Akiko Uenaka; Eiichi Nakayama
Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.
International journal of cancer. Journal international du cancer 2013;132(2):345-54.
2012: Hisashi Wada; Yuichiro Doki; Eiichi Nakayama
[Immune monitoring and cancer vaccine].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(12):2183-8.
2012: Junji Kawada; Hiroshi Miyata; Naoaki Mizuno; Roger Murphy; Yurika Nakamura; Yuichiro Doki; Shinichi Fujiwara; Sacha Gnjatic; Midori Isobe; Achim A Jungbluth; Hiroyoshi Nishikawa; Nami Okazaki; Lloyd J Old; Linda Pan; Erika Ritter; Gerd Ritter; Takashi Saika; Akiko Uenaka; Ralph Venhaus; Hisashi Wada; Makoto Yamasaki; Eiichi Nakayama
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2012;130(3):584-92.
2012: Tadashi Hanafusa; Ali Eldib Ali Mohamed; Eiichi Nakayama; Shohei Domae; Toshiro Ono
Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity.
BMC cancer 2012;12():520.
2011: Tadashi Hanafusa; Ali Eldib Ali Mohamed; Kenta Kitaoka; Yoshihiro Ohue; Eiichi Nakayama; Toshiro Ono
Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.
Cancer letters 2011;301(1):57-62.
2010: Shingo Eikawa; Yoshihiro Ohue; Kenta Kitaoka; Toshiki Aji; Akiko Uenaka; Mikio Oka; Eiichi Nakayama
Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(11):6734-40.
2010: Yu Mizote; Taku Taniguchi; Kei Tanaka; Midori Isobe; Hisashi Wada; Takashi Saika; Shoichi Kita; Yukari Koide; Akiko Uenaka; Eiichi Nakayama
Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.
Vaccine 2010;28(32):5338-46.
2009: Shohei Domae; Yoichi Nakamura; Yurika Nakamura; Akiko Uenaka; Hisashi Wada; Masao Nakata; Mikio Oka; Koji Kishimoto; Goichi Tsukamoto; Yasuto Yoshihama; Junji Matsuoka; Akira Gochi; Shigeru Kohno; Takashi Saika; Akira Sasaki; Eiichi Nakayama; Toshiro Ono
Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.
International journal of cancer. Journal international du cancer 2009;124(10):2347-52.
2009: Midori Isobe; Shingo Eikawa; Akiko Uenaka; Yoichi Nakamura; Tetsuo Kanda; Shigeru Kohno; Kiyotaka Kuzushima; Eiichi Nakayama
Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.
Cancer immunity 2009;9():8.
2008: Hisashi Wada; Eiichi Sato; Akiko Uenaka; Midori Isobe; Ryohei Kawabata; Yurika Nakamura; Shigemichi Iwae; Kouichiro Yonezawa; Makoto Yamasaki; Hiroshi Miyata; Yuichiro Doki; Hiroshi Shiku; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric W Hoffman; Lloyd J Old; Morito Monden; Eiichi Nakayama
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2008;123(10):2362-9.
2008: Hisashi Wada; Yuichiro Doki; Eiichi Nakayama
[Cancer vaccine].
Nihon rinsho. Japanese journal of clinical medicine 2008;66(10):2004-7.
2008: Kazuhide Tsuji; Toshitada Hamada; Akiko Uenaka; Hisashi Wada; Eiichi Sato; Midori Isobe; Kenji Asagoe; Osamu Yamasaki; Hiroshi Shiku; Gerd Ritter; Roger Murphy; Eric W Hoffman; Lloyd J Old; Eiichi Nakayama; Keiji Iwatsuki
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
Cancer immunology, immunotherapy : CII 2008;57(10):1429-37.
2008: Savas Kaya; Akiko Uenaka; Shuichiro Sato; Toshiro Ono; Toshiki Aji; Eiichi Nakayama
Identification of a CD4 T-cell epitope in tumor rejection antigen RLakt on BALB/c radiation-leukemia RL male 1.
Cancer science 2008;99(7):1441-7.
2008: Toshiaki Ishida; Yuichi Obata; Nobuya Ohara; Hirokazu Matsushita; Shuichiro Sato; Akiko Uenaka; Takashi Saika; Takako Miyamura; Kosuke Chayama; Yurika Nakamura; Hisashi Wada; Toshiharu Yamashita; Tsuneo Morishima; Lloyd J Old; Eiichi Nakayama
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity.
Cancer immunity 2008;8():15.
2007: Ryohei Kawabata; Hisashi Wada; Midori Isobe; Takashi Saika; Shuichiro Sato; Akiko Uenaka; Hiroshi Miyata; Takushi Yasuda; Yuichiro Doki; Yuji Noguchi; Hiromi Kumon; Kazuhide Tsuji; Keiji Iwatsuki; Hiroshi Shiku; Gerd Ritter; Roger Murphy; Eric Hoffman; Lloyd J Old; Morito Monden; Eiichi Nakayama
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients.
International journal of cancer. Journal international du cancer 2007;120(10):2178-84.
2007: Michihide Shimono; Akiko Uenaka; Yuji Noguchi; Shuichiro Sato; Hideo Okumura; Kazuhiko Nakagawa; Katsuyuki Kiura; Mitsune Tanimoto; Eiichi Nakayama
Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells.
International journal of oncology 2007;30(4):835-40.
2007: Yoshiyuki Morishita; Akiko Uenaka; Savas Kaya; Shuichiro Sato; Toshiki Aji; Eiichi Nakayama
HLA-DRB1*0410-restricted recognition of XAGE-1b37-48 peptide by CD4 T cells.
Microbiology and immunology 2007;51(8):755-62.
2007: Akiko Uenaka; Hisashi Wada; Midori Isobe; Takashi Saika; Kazuhide Tsuji; Eiichi Sato; Shuichiro Sato; Yuji Noguchi; Ryohei Kawabata; Takushi Yasuda; Yuichiro Doki; Hiromi Kumon; Keiji Iwatsuki; Hiroshi Shiku; Morito Monden; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric Hoffman; Lloyd J Old; Eiichi Nakayama
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Cancer immunity 2007;7():9.
2007: Shuichiro Sato; Yuji Noguchi; Nobuya Ohara; Akiko Uenaka; Michihide Shimono; Kazuhiko Nakagawa; Fumihito Koizumi; Toshiaki Ishida; Tadashi Yoshino; Yasushi Shiratori; Eiichi Nakayama
Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors.
Cancer immunity 2007;7():5.
2006: Jonathan Tammela; Akiko Uenaka; Toshiro Ono; Yuji Noguchi; Achim A Jungbluth; Paulette Mhawech-Fauceglia; Feng Qian; Sally Schneider; Sameer Sharma; Deborah Driscoll; Shashikant Lele; Lloyd J Old; Eiichi Nakayama; Kunle Odunsi
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
International journal of oncology 2006;29(4):903-10.
2006: Kosei Hasegawa; Yuji Noguchi; Fumihito Koizumi; Akiko Uenaka; Motoyuki Tanaka; Michihide Shimono; Hideo Nakamura; Hiroshi Shiku; Sacha Gnjatic; Roger Murphy; Yuji Hiramatsu; Lloyd J Old; Eiichi Nakayama
In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1921-7.
2005: Hirokazu Matsushita; Akiko Uenaka; Toshiro Ono; Kosei Hasegawa; Shuichiro Sato; Fumihito Koizumi; Kazuhiko Nakagawa; Masahiro Toda; Tetsuro Shingo; Tomotsugu Ichikawa; Yuji Noguchi; Takashi Tamiya; Tomohisa Furuta; Takeshi Kawase; Isao Date; Eiichi Nakayama
Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients.
Cancer science 2005;96(11):801-9.
2005: Kazuhiko Nakagawa; Yuji Noguchi; Akiko Uenaka; Shuichiro Sato; Hideo Okumura; Motoyuki Tanaka; Michihide Shimono; Ali Mohamed Ali ُEldib; Toshiro Ono; Nobuya Ohara; Tadashi Yoshino; Kazuki Yamashita; Tsukasa Tsunoda; Motoi Aoe; Nobuyoshi Shimizu; Eiichi Nakayama
XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5496-503.
2005: Akiko Uenaka; Eiichi Nakayama
[Tumor specific antigen and cytotoxic T lymphocytes].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 4():568-73.
2005: Hideo Okumura; Yuji Noguchi; Akiko Uenaka; Toshiki Aji; Toshiro Ono; Kazuhiko Nakagawa; Motoi Aoe; Nobuyoshi Shimizu; Eiichi Nakayama
Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells.
Microbiology and immunology 2005;49(11):1009-16.
2005: Fumihito Koizumi; Yuji Noguchi; Takashi Saika; Kazuhiko Nakagawa; Shuichiro Sato; Ali Mohamed Ali Eldib; Yasutomo Nasu; Hiromi Kumon; Eiichi Nakayama
XAGE-1 mRNA expression in prostate cancer and antibody response in patients.
Microbiology and immunology 2005;49(5):471-6.
2005: Shuichiro Sato; Yuji Noguchi; Hisashi Wada; Shoichiro Fujita; Shinichiro Nakamura; Ryo Tanaka; Tetsuya Nakada; Kosei Hasegawa; Kazuhiko Nakagawa; Fumihito Koizumi; Toshiro Ono; Kazuhiro Nouso; Achim Jungbluth; Yao-Tseng Chen; Lloyd J Old; Yasushi Shiratori; Eiichi Nakayama
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
International journal of oncology 2005;26(1):57-63.
2004: Kosei Hasegawa; Fumihito Koizumi; Yuji Noguchi; Atsushi Hongo; Yasushi Mizutani; Junichi Kodama; Yuji Hiramatsu; Eiichi Nakayama
SSX expression in gynecological cancers and antibody response in patients.
Cancer immunity 2004;4():16.
2004: Shoichiro Fujita; Hisashi Wada; Achim A Jungbluth; Shuichiro Sato; Tetsuya Nakata; Yuji Noguchi; Yuichiro Doki; Masayoshi Yasui; Yurika Sugita; Takushi Yasuda; Masahiko Yano; Toshiro Ono; Yao-Tseng Chen; Masahiko Higashiyama; Sacha Gnjatic; Lloyd J Old; Eiichi Nakayama; Morito Monden
NY-ESO-1 expression and immunogenicity in esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6551-8.
2004: Yurika Sugita; Hisashi Wada; Shoichiro Fujita; Tetsuya Nakata; Shuichiro Sato; Yuji Noguchi; Achim A Jungbluth; Masae Yamaguchi; Yao-Tseng Chen; Elisabeth Stockert; Sacha Gnjatic; Barbara Williamson; Matthew J Scanlan; Toshiro Ono; Isao Sakita; Masayoshi Yasui; Yasuo Miyoshi; Yasuhiro Tamaki; Nariaki Matsuura; Shinzaburo Noguchi; Lloyd J Old; Eiichi Nakayama; Morito Monden
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
Cancer research 2004;64(6):2199-204.
2004: Itsuro Takada; Yuji Noguchi; Akira Kenjo; Hisashi Wada; Akiko Uenaka; Teizo Fujita; Hajime Inoue; Eiichi Nakayama
Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.
Cancer science 2004;95(3):254-9.
2004: Ali Mohamed Ali ُEldib; Toshiro Ono; Michihide Shimono; Miho Kaneko; Kazuhiko Nakagawa; Ryo Tanaka; Yuji Noguchi; Eiichi Nakayama
Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
International journal of cancer. Journal international du cancer 2004;108(4):558-63.
2004: Motoyuki Tanaka; Masaharu Yamada; Toshiro Ono; Yuji Noguchi; Akiko Uenaka; Seisuke Ota; Hidenori Hata; Mine Harada; Mitsune Tanimoto; Eiichi Nakayama
Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T-lymphocytes and the GM-CSF gene by in vivo electroporation.
Cancer science 2004;95(2):154-9.
2004: Miho Kaneko; Toshiro Ono; Tomoyo Matsubara; Yukiyo Yamamoto; Hitoshi Ikeda; Takashi Yoshiki; Susumu Furukawa; Eiichi Nakayama
Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning.
Microbiology and immunology 2004;48(9):703-11.
2004: Kosei Hasegawa; Toshiro Ono; Hirokazu Matsushita; Michihide Shimono; Yuji Noguchi; Yasushi Mizutani; Junichi Kodama; Takafumi Kudo; Eiichi Nakayama
A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis.
International journal of cancer. Journal international du cancer 2004;108(1):86-90.
2003: Akiko Uenaka; Eiichi Nakayama
Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).
Cancer science 2003;94(11):931-6.
2003: Tetsuya Nakada; Yuji Noguchi; Shuichiro Satoh; Toshiro Ono; Takashi Saika; Takushi Kurashige; Sacha Gnjatic; Gerd Ritter; Yao-Tseng Chen; Elisabeth Stockert; Yasutomo Nasu; Tomoyasu Tsushima; Hiromi Kumon; Lloyd J Old; Eiichi Nakayama
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
Cancer immunity 2003;3():10.
2003: Akiko Uenaka; Yoshiki Hirano; Hidenori Hata; Sanda Win; Toshiki Aji; Motoyuki Tanaka; Toshiro Ono; Jonathan C A Skipper; Kenji Shimizu; Eiichi Nakayama
Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(9):4862-8.
2002: Isao Tawara; Yutaka Take; Akiko Uenaka; Yuji Noguchi; Eiichi Nakayama
Sequential involvement of two distinct CD4+ regulatory T cells during the course of transplantable tumor growth and protection from 3-methylcholanthrene-induced tumorigenesis by CD25-depletion.
Japanese journal of cancer research : Gann 2002;93(8):911-6.
2002: Hidenori Hata; Akiko Uenaka; Itsuro Takada; Akira Kenjo; Minoru Takahashi; Toshiro Ono; Teizo Fujita; Eiichi Nakayama
Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
International journal of oncology 2002;20(5):1019-25.
2002: Seisuke Ota; Toshiro Ono; Akimichi Morita; Akiko Uenaka; Mine Harada; Eiichi Nakayama
Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells.
Cancer research 2002;62(5):1471-6.
2002: Sanda Win; Akiko Uenaka; Eiichi Nakayama
Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice.
Microbiology and immunology 2002;46(7):513-9.
2001: Akiko Uenaka; Hidenori Hata; Sanda Win; Toshiro Ono; Hisashi Wada; Eiichi Nakayama
ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library.
Cancer immunity 2001;1():8.
2001: Takushi Kurashige; Yuji Noguchi; Takashi Saika; Toshiro Ono; Y Nagata; Achim Jungbluth; Gerd Ritter; Yao-Tseng Chen; Elisabeth Stockert; Tomoyasu Tsushima; Hiromi Kumon; Lloyd J Old; Eiichi Nakayama
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
Cancer research 2001;61(12):4671-4.
2001: Toshiro Ono; Takushi Kurashige; N Harada; Yuji Noguchi; Takashi Saika; N Niikawa; M Aoe; S Nakamura; T Higashi; A Hiraki; Hisashi Wada; Hiromi Kumon; Lloyd J Old; Eiichi Nakayama
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3282-7.
2000: Toshiro Ono; Shuichiro Sato; N Kimura; Motoyuki Tanaka; A Shibuya; Lloyd J Old; Eiichi Nakayama
Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
International journal of cancer. Journal international du cancer 2000;88(6):845-51.
1999: S Onizuka; Isao Tawara; J Shimizu; S Sakaguchi; T Fujita; Eiichi Nakayama
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.
Cancer research 1999;59(13):3128-33.
1999: M Matsuo; H Wada; S Honda; Isao Tawara; Akiko Uenaka; T Kanematsu; Eiichi Nakayama
Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6420-5.
1998: S Honda; H Wada; Akiko Uenaka; Eiichi Nakayama
Possible involvement of autoreactive CD4 T cells in generation of cytotoxic T lymphocytes on in vitro stimulation with H-2 class I-binding tumor antigen peptide.
International immunology 1998;10(8):1167-74.
1998: A Manki; T Ono; Akiko Uenaka; Y Seino; Eiichi Nakayama
Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
Cancer research 1998;58(9):1960-4.
1996: T Ono; Akiko Uenaka; Eiichi Nakayama
Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.
Japanese journal of cancer research : Gann 1996;87(11):1165-70.
1996: B G Chen; H Wada; T Matsutake; Akiko Uenaka; Y Obata; Eiichi Nakayama
Inhibition by CsA and FK506 of the in vitro proliferative response of gamma delta T cells on stimulation with anti-TCR delta monoclonal antibody.
Transplant immunology 1996;4(2):158-62.
1996: Akiko Uenaka; Eiichi Nakayama
[Analysis of tumor rejection antigen peptides recognized by specific CTL].
Nihon rinsho. Japanese journal of clinical medicine 1996;54(1):242-9.
1995: H Wada; M Matsuo; Akiko Uenaka; N Shimbara; K Shimizu; Eiichi Nakayama
Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5' region of the c-akt proto-oncogene activated by long terminal repeat.
Cancer research 1995;55(21):4780-3.
1995: H Wada; T Ono; Akiko Uenaka; M Monden; Eiichi Nakayama
Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.
Immunology 1995;84(4):633-7.